1. Home
  2. CTS vs MLTX Comparison

CTS vs MLTX Comparison

Compare CTS & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CTS Corporation

CTS

CTS Corporation

HOLD

Current Price

$57.85

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$12.51

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTS
MLTX
Founded
1896
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CTS
MLTX
Price
$57.85
$12.51
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$27.50
AVG Volume (30 Days)
127.0K
1.2M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
0.29%
N/A
EPS Growth
15.87
N/A
EPS
0.59
N/A
Revenue
$541,318,000.00
N/A
Revenue This Year
$5.55
N/A
Revenue Next Year
$5.00
N/A
P/E Ratio
$95.15
N/A
Revenue Growth
4.95
N/A
52 Week Low
$36.03
$5.95
52 Week High
$69.55
$62.75

Technical Indicators

Market Signals
Indicator
CTS
MLTX
Relative Strength Index (RSI) 36.91 23.93
Support Level $55.17 $13.09
Resistance Level $58.03 $15.48
Average True Range (ATR) 1.40 0.57
MACD -0.02 -0.11
Stochastic Oscillator 32.05 1.20

Price Performance

Historical Comparison
CTS
MLTX

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: